SynthesisSurgical endoscopy2026
Comparing oncologic and surgical outcomes of robotic and open pancreatoduodenectomy: an updated meta-analysis.
Synthesis in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo compare perioperative and oncologic outcomes of robotic pancreaticoduodenectomy (RPD) versus open pancreaticoduodenectomy (OPD) using evidence from cohort studies in a systematic review.
methodsThis is a systematic review and meta-analysis comparing outcomes between RPD and OPD. Intraoperative outcomes were operative time, estimated blood loss, lymph node yield, R0 resection, and R1 resection. Post-operative outcomes were overall complication rates, Clavien-Dindo ≥ 3, post-operative pancreatic fistula, bile leak, delayed gastric emptying, post-pancreatectomy hemorrhage, wound infection, length of stay, re-admission, re-operation, short-term mortality, and long-term mortality. Fixed-effects model or random-effects model was used to pool results. Heterogeneity was assessed using I
resultsFourteen studies met inclusion criteria, including 2862 patients (1087 in the RPD group and 1775 in the OPD group). The RPD group was associated with longer operative times, less blood loss, lower risk of overall complications, long-term mortality, and short-term mortality, and shorter length of stay. No other significant differences in outcomes were detected between the groups.
conclusionRPD achieved superior perioperative clinical outcomes and comparable oncologic outcomes. These findings suggest that robotic pancreatoduodenectomy may offer a promising alternative to open surgery.
Indexed as
Identifiers
42377469What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.